[Hemotherapeutic safeguarding of induced abortion in inborn proconvertin insufficiency (hemagglutination factor VII) using exchange plasmapheresis].
D000028:Abortion, Induced / Q000009:adverse effects*; D000328:Adult; D005167:Factor VII / Q000096:biosynthesis; D005168:Factor VII Deficiency / Q000150:complications / Q000151:congenital; D005260:Female; D006801:Humans; D008722:Methods; D010956:Plasmapheresis; D011247:Pregnancy; D014592:Uterine Hemorrhage / Q000209:etiology / Q000517:prevention & control*
D005167:Factor VII
Hämotherapeutische Sicherung der Interruption bei angeborenem Mangel des Prokonvertins (des Hämokoagulationsfaktors VII) mittels der Methode der Austauschplasmapherese.